SG Americas Securities’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $261K | Sell |
60,000
-930,800
| -94% | -$206M | ﹤0.01% | 2518 |
|
|
2025
Q4 | $7.77M | Sell |
990,800
-310,800
| -24% | -$70.8M | 0.01% | 887 |
|
|
2025
Q3 | $18.8M | Buy |
1,301,600
+1,205,400
| +1,253% | +$245M | 0.06% | 207 |
|
|
2025
Q2 | $840K | Sell |
96,200
-105,900
| -52% | -$19.7M | ﹤0.01% | 1298 |
|
|
2025
Q1 | $2.81M | Sell |
202,100
-369,400
| -65% | -$71.8M | 0.01% | 669 |
|
|
2024
Q4 | $2.33M | Buy |
571,500
+110,000
| +24% | +$20.2M | 0.01% | 552 |
|
|
2024
Q3 | $6.05M | Buy |
461,500
+133,900
| +41% | +$25M | 0.02% | 362 |
|
|
2024
Q2 | $2.27M | Buy |
327,600
+87,500
| +36% | +$14.5M | 0.01% | 890 |
|
|
2024
Q1 | $5.95M | Sell |
240,100
-57,300
| -19% | -$9.88M | 0.03% | 492 |
|
|
2023
Q4 | $2.57M | Buy |
297,400
+149,900
| +102% | +$21.9M | 0.02% | 575 |
|
|
2023
Q3 | $652K | Buy |
147,500
+25,100
| +21% | +$3.68M | 0.01% | 1563 |
|
|
2023
Q2 | $133K | Sell |
122,400
-469,500
| -79% | -$68.8M | ﹤0.01% | 1963 |
|
|
2023
Q1 | $4.05M | Buy |
591,900
+547,900
| +1,245% | +$83.8M | 0.05% | 346 |
|
|
2022
Q4 | $268K | Hold |
44,000
| – | – | ﹤0.01% | 2005 |
|
|
2022
Q3 | $103K | Hold |
44,000
| – | – | ﹤0.01% | 2845 |
|
|
2022
Q2 | $356K | Sell |
44,000
-455,700
| -91% | -$69.6M | ﹤0.01% | 2250 |
|
|
2022
Q1 | $2.23M | Buy |
499,700
+457,200
| +1,076% | +$66.4M | 0.02% | 843 |
|
|
2021
Q4 | $842K | Buy |
42,500
+25,000
| +143% | +$2.95M | ﹤0.01% | 1770 |
|
|
2021
Q3 | $72K | Sell |
17,500
-27,500
| -61% | -$3.14M | ﹤0.01% | 3704 |
|
|
2021
Q2 | $696K | Sell |
45,000
-39,400
| -47% | -$4.44M | ﹤0.01% | 1772 |
|
|
2021
Q1 | $613K | Sell |
84,400
-85,600
| -50% | -$9.16M | ﹤0.01% | 1870 |
|
|
2020
Q4 | $2.96M | Sell |
170,000
-256,000
| -60% | -$24.6M | 0.02% | 823 |
|
|
2020
Q3 | $4.67M | Sell |
426,000
-5,500
| -1% | -$518K | 0.03% | 373 |
|
|
2020
Q2 | $8.1M | Sell |
431,500
-478,500
| -53% | -$42.1M | 0.07% | 217 |
|
|
2020
Q1 | $4.97M | Sell |
910,000
-745,100
| -45% | -$63.5M | 0.05% | 382 |
|
|
2019
Q4 | $15.9M | Buy |
1,655,100
+410,000
| +33% | +$34M | 0.15% | 104 |
|
|
2019
Q3 | $5.45M | Buy |
1,245,100
+1,230,700
| +8,547% | +$84.4M | 0.04% | 429 |
|
|
2019
Q2 | $3K | Sell |
14,400
-46,700
| -76% | -$3.67M | ﹤0.01% | 3027 |
|
|
2019
Q1 | $17K | Sell |
61,100
-157,200
| -72% | -$12.9M | ﹤0.01% | 3278 |
|
|
2018
Q4 | $2.49M | Hold |
218,300
| – | – | 0.02% | 727 |
|
|
2018
Q3 | $3.02M | Hold |
218,300
| – | – | 0.02% | 859 |
|
|
2018
Q2 | $3.04M | Sell |
218,300
-90,100
| -29% | -$8.8M | 0.03% | 683 |
|
|
2018
Q1 | $4.91M | Sell |
308,400
-892,100
| -74% | -$98M | 0.04% | 429 |
|
|
2017
Q4 | $19.8M | Buy |
1,200,500
+642,700
| +115% | +$60.6M | 0.19% | 88 |
|
|
2017
Q3 | $7.79M | Buy |
557,800
+212,100
| +61% | +$16.1M | 0.07% | 215 |
|
|
2017
Q2 | $1.28M | Sell |
345,700
-676,300
| -66% | -$45.5M | 0.01% | 1217 |
|
|
2017
Q1 | $457K | Buy |
1,022,000
+978,700
| +2,260% | +$61.5M | ﹤0.01% | 1907 |
|
|
2016
Q4 | $39K | Sell |
43,300
-59,300
| -58% | -$3.62M | ﹤0.01% | 2946 |
|
|
2016
Q3 | $93K | Sell |
102,600
-199,100
| -66% | -$12.9M | ﹤0.01% | 3088 |
|
|
2016
Q2 | $164K | Buy |
301,700
+258,400
| +597% | +$15.7M | ﹤0.01% | 2190 |
|
|
2016
Q1 | $78K | Sell |
43,300
-97,500
| -69% | -$5.43M | ﹤0.01% | 2685 |
|
|
2015
Q4 | $36K | Buy |
+140,800
| New | +$8.11M | ﹤0.01% | 2503 |
|
|
2015
Q3 | – | Sell |
-103,800
| Closed | -$371K | – | 2029 |
|
|
2015
Q2 | $371K | Buy |
103,800
+53,800
| +108% | +$3.51M | ﹤0.01% | 1637 |
|
|
2015
Q1 | $144K | Hold |
50,000
| – | – | ﹤0.01% | 2067 |
|
|
2014
Q4 | $317K | Buy |
50,000
+14,500
| +41% | +$914K | ﹤0.01% | 2016 |
|
|
2014
Q3 | $176K | Hold |
35,500
| – | – | ﹤0.01% | 2040 |
|
|
2014
Q2 | $136K | Buy |
+35,500
| New | +$1.86M | ﹤0.01% | 2221 |
|
Other funds holding ABBV
VCM
VPM
SG Americas Securities's ABBV Position: Q1 2026 in Review
SG Americas Securities increased its AbbVie (ABBV) stake by 117% in Q1 2026, buying an estimated $136M and bringing the position to 1,135,261 shares worth $247M. The position accounts for 0.27% of the portfolio, ranked #51.
SG Americas Securities first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- SG Americas Securities held 1,135,261 shares of AbbVie worth $247M as of Q1 2026.
- SG Americas Securities bought 612,667 AbbVie shares in Q1 2026, an estimated $136M.
- AbbVie made up 0.27% of SG Americas Securities's portfolio in Q1 2026, its #51 holding.
- SG Americas Securities first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.